Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;57(1):E1-4.

Influenza vaccination: from epidemiological aspects and advances in research to dissent and vaccination policies

Affiliations

Influenza vaccination: from epidemiological aspects and advances in research to dissent and vaccination policies

R Gasparini et al. J Prev Med Hyg. 2016.

Abstract

Influenza is a serious public health problem, since seasonal epidemics affect approximately 5-10% of the population and thus give rise to a heavy social and healthcare burden. The heavy burden of disease is due to several factors, one of which is the biological features of the pathogen. Indeed influenza viruses display high mutation rates and undergo frequent genetic reassortment. Minor variations cause seasonal epidemics and major variations, which result from the hybridization of viruses typical of different animal species, can lead to pandemics. Vaccination remains the most efficacious means of mitigating the harmful healthcare and social effects of influenza. Influenza vaccines have evolved over time in order to offer broader protection against circulating strains. Trivalent vaccines containing two A viruses and one B virus are currently available. However, given the co-circulation of both B virus lineages (B/Yamagata and B/Victoria), quadrivalent vaccines have recently been developed. The new quadrivalent vaccines constitute a great advance, in that they can offer broader strain coverage. Despite the availability of effective and safe influenza vaccines, the Italian public's trust in vaccination has declined and, in the last few years, influenza vaccination coverage rates have decreased both among the elderly and among at-risk adults. It is therefore necessary that users, in their own interests, regain trust in this important means of disease prevention. In order to mitigate the damage wreaked by influenza, it seems important to: (i) improve clinical-epidemiological and virological surveillance of the disease; (ii) promote the development of new efficacious vaccines, as has recently been done through the introduction of the quadrivalent vaccine; (iii) extend free vaccination to the entire population, as in the US and Canada; (iv) ensure that general healthcare professionals are properly informed and always updated with regard to vaccination; (v) promote public campaigns to raise the population's awareness of the importance of vaccination; (vi) inform politicians and other decision-makers of scientific results in the field of vaccination; (vii) fight the antivaccination lobbies with every available weapon.

Keywords: Dissent; Influenza; Influenza vaccine.

PubMed Disclaimer

References

    1. WHO. Influenza (Seasonal). Available at: http://www.who.int/mediacentre/factsheets/fs211/en/ [Accessed on 15/02/16]
    1. Hay A, Gregory V, Douglas A, Lin Y. The evolution of human influenza viruses . Philos Trans R Soc Lond B Biol Sci. 2001;356:1861–1870. - PMC - PubMed
    1. Noda T. Native morphology of influenza virions . Front Microbiol. 2012;2:269–269. - PMC - PubMed
    1. Gasparini R, Amicizia D, Lai PL, Bragazzi NL, Panatto D. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: influenza life-cycle and currently available drugs . J Prev Med Hyg. 2014;55:69–85. - PMC - PubMed
    1. Bridges CB, Katz JM, Levandowski RA, Cox NJ. Inactivated influenza vaccines. In: Plotkin S, Orenstein W, Offit P, editors. Vaccines. Fifth Edition. Philadelphia: Saunders Elsevier; 2008. pp. 260–290.

Substances

LinkOut - more resources